Cabot Corporation (CBT) reported $3.63B of revenue for the twelve months ended Jun 30, 2026. That is down 4.7% from the year before. Revenue for fiscal 2025 was $3.71B.

Yes. Cabot Corporation earned $209.00M in net income for the twelve months ended Jun 30, 2026, a net margin of 5.8%.

How much cash and debt does CBT have?

Cabot Corporation reported $250.00M in cash and cash equivalents and $1.09B of debt on its most recent balance sheet in SEC filings.

How fast is CBT revenue growing?

Cabot Corporation's revenue changed -7.0% in fiscal 2025, to $3.71B. Its compound annual growth rate was +7.3% over 5 years and +2.6% over 10 years.

What is CBT gross margin?

Cabot Corporation's gross profit was $825.00M on $3.63B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 22.7%.

What is CBT free cash flow?

Cabot Corporation generated $281.00M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $497.00M less capital expenditures.

What is CBT earnings per share?

Diluted earnings per share were $3.56 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CBT last report financial results?

The latest statements here come from Cabot Corporation's 10-Q filed on Aug 4, 2026, covering the period ended Jun 30, 2026.

Where does this CBT financial data come from?

Quantisnow builds these statements from the structured XBRL data Cabot Corporation files with the SEC. It is provided for information only and is not investment advice.

Financials · CBT

Cabot Corporation (CBT) financials

For the twelve months ended Jun 30, 2026, Cabot Corporation reported $3.63B of revenue and $209.00M of net income.

Revenue, TTM: $3.63B
Revenue growth, YoY: -4.7%
Net income, TTM: $209.00M
Net income growth, YoY: -53.2%
Net margin: 5.8%
Free cash flow, TTM: $281.00M
EPS, diluted, TTM: $3.56
EPS growth, YoY: -53.3%
Cash: $250.00M
Total debt: $1.09B
P/E: 17.83
P/S: 1.03
Market cap: $3.73B

Annual revenue$3.71B

FY2016FY2025

Annual net income$331.00M

FY2016FY2025

Annual free cash flow$391.00M

FY2016FY2025

CBT revenue and earnings growth

CBT revenueQ3 2026$982.00M

Quarter YoY: +6.4%
QoQ: +8.6%
FY YoY: -7.0%
5Y CAGR: +7.3%
10Y CAGR: +2.6%

CBT revenue was $982.00M in fiscal Q3 2026 (ended Jun 30, 2026), up 6.4% from a year earlier and up 8.6% from the prior quarter. For the full fiscal 2025 it was $3.71B, down 7.0% from fiscal 2024. Compound annual growth was +7.3% over 5 years and +2.6% over 10 years. It rose in 6 of the last 10 fiscal years.

CBT net incomeQ3 2026$6.00M

Quarter YoY: -94.1%
QoQ: -92.3%
FY YoY: -12.9%

CBT net income was $6.00M in fiscal Q3 2026 (ended Jun 30, 2026), down 94.1% from a year earlier and down 92.3% from the prior quarter. For the full fiscal 2025 it was $331.00M, down 12.9% from fiscal 2024. It rose in 1 of the last 4 fiscal years.

CBT EPSQ3 2026$0.12

Quarter YoY: -93.5%
QoQ: -90.6%
FY YoY: -10.4%

CBT diluted EPS was $0.12 in fiscal Q3 2026 (ended Jun 30, 2026), down 93.5% from a year earlier and down 90.6% from the prior quarter. For the full fiscal 2025 it was $6.02, down 10.4% from fiscal 2024.

CBT free cash flowQ3 2026$37.00M

Quarter YoY: -80.3%
QoQ: +15.6%
FY YoY: -13.3%
5Y CAGR: +17.2%
10Y CAGR: +0.9%

CBT free cash flow was $37.00M in fiscal Q3 2026 (ended Jun 30, 2026), down 80.3% from a year earlier and up 15.6% from the prior quarter. For the full fiscal 2025 it was $391.00M, down 13.3% from fiscal 2024. Compound annual growth was +17.2% over 5 years and +0.9% over 10 years.

Export CSV

Income statement

Income statement
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue	$3.71B	$3.99B	$3.93B	$4.32B	$3.41B	$2.61B	$3.34B	$3.24B	$2.72B	$2.41B
Cost of revenue	$2.77B	$3.03B	$3.09B	$3.44B	$2.61B	$2.11B	$2.65B	$2.47B	$2.06B	$1.84B
Gross profit	$940.00M	$960.00M	$839.00M	$885.00M	$799.00M	$500.00M	$685.00M	$772.00M	$657.00M	$575.00M
Research and development	$59.00M	$63.00M	$57.00M	$55.00M	$56.00M	$57.00M	$60.00M	$66.00M	$57.00M	$53.00M
Selling, general and admin	$260.00M	$283.00M	$253.00M	$258.00M	$289.00M	$292.00M	$290.00M	$308.00M	$262.00M	$275.00M
Operating income	$621.00M	$614.00M	$526.00M	$389.00M	$454.00M	$21.00M	$306.00M	$144.00M	$338.00M	$247.00M
Interest expense	$76.00M	$81.00M	$90.00M	$56.00M	$49.00M	$53.00M	$59.00M	$54.00M	$53.00M	$54.00M
Pre-tax income	$565.00M	$529.00M	$451.00M	$335.00M	$406.00M	-$33.00M	$255.00M	$117.00M	$299.00M	$191.00M
Income tax	$196.00M	$111.00M	-$28.00M	$102.00M	$123.00M	$191.00M	$70.00M	$193.00M	$33.00M	$33.00M
Net income	$331.00M	$380.00M	$445.00M	$209.00M	$250.00M	-$238.00M	$157.00M	-$113.00M	$248.00M	$147.00M
EPS, basic	$6.07	$6.79	$7.79	$3.65	$4.35	-$4.21	$2.64	-$1.85	$3.94	$2.34
EPS, diluted	$6.02	$6.72	$7.73	$3.62	$4.34	-$4.21	$2.63	-$1.85	$3.91	$2.32
Diluted shares	54.2M	55.7M	56.5M	56.9M	56.8M	56.6M	58.8M	61.7M	62.7M	62.9M

Balance sheet

Balance sheet
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Cash and equivalents	$258.00M	$223.00M	$238.00M	$206.00M	$168.00M	$151.00M	$169.00M	$175.00M	$280.00M	$200.00M
Inventory	$504.00M	$552.00M	$585.00M	$664.00M	$523.00M	$359.00M	$466.00M	$511.00M	$433.00M	$342.00M
Current assets	$1.54B	$1.60B	$1.63B	$1.82B	$1.43B	$978.00M	$1.21B	$1.39B	$1.30B	$1.05B
Goodwill	$134.00M	$133.00M	$134.00M	$129.00M	$140.00M	$134.00M	$90.00M	$93.00M	$154.00M	$152.00M
Total assets	$3.81B	$3.74B	$3.60B	$3.52B	$3.31B	$2.78B	$3.00B	$3.24B	$3.34B	$3.05B
Current liabilities	$957.00M	$772.00M	$822.00M	$1.10B	$1.15B	$529.00M	$599.00M	$952.00M	$742.00M	$397.00M
Short-term debt	$260.00M	$8.00M	$8.00M	$7.00M	$373.00M	$7.00M	$7.00M	$35.00M	$256.00M	$1.00M
Long-term debt	$856.00M	$1.09B	$1.09B	$1.09B	$717.00M	$1.09B	$1.02B	$719.00M	$661.00M	$914.00M
Total debt	$1.12B	$1.09B	$1.10B	$1.10B	$1.09B	$1.10B	$1.03B	$754.00M	$917.00M	$915.00M
Total liabilities	$2.11B	$2.15B	$2.20B	$2.49B	$2.22B	$1.97B	$1.87B	$1.97B	$1.71B	$1.65B
Shareholders' equity	$1.55B	$1.59B	$1.41B	$1.03B	$1.09B	$814.00M	$1.13B	$1.28B	$1.63B	$1.39B

Cash flow

Cash flow
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Operating cash flow	$665.00M	$692.00M	$595.00M	$100.00M	$257.00M	$377.00M	$363.00M	$298.00M	$348.00M	$392.00M
Capital expenditures	$274.00M	$241.00M	$244.00M	$211.00M	$195.00M	$200.00M	$224.00M	$229.00M	$147.00M	$112.00M
Free cash flow	$391.00M	$451.00M	$351.00M	-$111.00M	$62.00M	$177.00M	$139.00M	$69.00M	$201.00M	$280.00M
Investing cash flow	-$298.00M	-$235.00M	-$214.00M	-$118.00M	-$186.00M	-$288.00M	-$94.00M	-$246.00M	-$149.00M	-$104.00M
Financing cash flow	-$336.00M	-$415.00M	-$403.00M	$145.00M	-$60.00M	-$132.00M	-$236.00M	-$141.00M	-$133.00M	-$184.00M
Dividends paid	$96.00M	$93.00M	$88.00M	$84.00M	$80.00M	$80.00M	$80.00M	$80.00M	$77.00M	$65.00M
Share repurchases	$168.00M	$172.00M	$98.00M	$53.00M	$3.00M	$44.00M	$173.00M	$142.00M	$61.00M	$45.00M
Stock-based compensation	$24.00M	$25.00M	$20.00M	$23.00M	$21.00M	$9.00M	$11.00M	$22.00M	$16.00M	$17.00M
Depreciation and amortization	$154.00M	$151.00M	$144.00M	$146.00M	$160.00M	$158.00M	$148.00M	$149.00M	$155.00M	$161.00M

Key ratios

Key ratios
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue growth, YoY	-7.0%	1.6%	-9.0%	26.8%	30.4%	-21.7%	2.9%	19.3%	12.7%	-16.0%
Net income growth, YoY	-12.9%	-14.6%	112.9%	-16.4%	-	-	-	-	68.7%	-
EPS growth, YoY	-10.4%	-13.1%	113.5%	-16.6%	-	-	-	-	68.5%	-
Gross margin	25.3%	24.0%	21.3%	20.5%	23.4%	19.1%	20.5%	23.8%	24.2%	23.8%
Operating margin	16.7%	15.4%	13.4%	9.0%	13.3%	0.8%	9.2%	4.4%	12.4%	10.2%
Net margin	8.9%	9.5%	11.3%	4.8%	7.3%	-9.1%	4.7%	-3.5%	9.1%	6.1%
Free cash flow margin	10.5%	11.3%	8.9%	-2.6%	1.8%	6.8%	4.2%	2.1%	7.4%	11.6%
Return on equity	21.4%	23.9%	31.6%	20.3%	22.9%	-29.2%	13.8%	-8.8%	15.3%	10.6%
Return on assets	8.7%	10.2%	12.3%	5.9%	7.6%	-8.6%	5.2%	-3.5%	7.4%	4.8%
Current ratio	1.61	2.08	1.98	1.65	1.24	1.85	2.02	1.46	1.75	2.64
Debt to equity	0.72	0.69	0.78	1.06	1.00	1.35	0.91	0.59	0.56	0.66

Income statement

Income statement
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Revenue	$982.00M	$904.00M	$849.00M	$899.00M	$923.00M	$936.00M	$955.00M	$1.00B	$1.02B	$1.02B	$958.00M	$965.00M
Cost of revenue	$798.00M	$694.00M	$638.00M	$679.00M	$679.00M	$695.00M	$720.00M	$761.00M	$760.00M	$773.00M	$740.00M	$740.00M
Gross profit	$184.00M	$210.00M	$211.00M	$220.00M	$244.00M	$241.00M	$235.00M	$240.00M	$256.00M	$246.00M	$218.00M	$225.00M
Research and development	$13.00M	$14.00M	$13.00M	$15.00M	$15.00M	$15.00M	$14.00M	$17.00M	$16.00M	$15.00M	$15.00M	$14.00M
Selling, general and admin	$73.00M	$67.00M	$69.00M	$68.00M	$62.00M	$64.00M	$66.00M	$73.00M	$68.00M	$75.00M	$67.00M	$69.00M
Operating income	$98.00M	$129.00M	$129.00M	$137.00M	$167.00M	$162.00M	$155.00M	$150.00M	$172.00M	$156.00M	$136.00M	$142.00M
Interest expense	$18.00M	$18.00M	$18.00M	$20.00M	$19.00M	$19.00M	$18.00M	$19.00M	$19.00M	$21.00M	$22.00M	$21.00M
Pre-tax income	$58.00M	$120.00M	$118.00M	$115.00M	$155.00M	$151.00M	$144.00M	$135.00M	$158.00M	$142.00M	$94.00M	$127.00M
Income tax	$46.00M	$44.00M	$37.00M	$63.00M	$43.00M	$49.00M	$41.00M	-$10.00M	$40.00M	$47.00M	$34.00M	-$118.00M
Net income	$6.00M	$78.00M	$82.00M	$43.00M	$101.00M	$105.00M	$104.00M	$137.00M	$109.00M	$97.00M	$61.00M	$234.00M
EPS, basic	$0.12	$1.27	$1.38	$0.80	$1.87	$1.71	$1.69	$2.45	$1.96	$1.50	$0.88	$4.10
EPS, diluted	$0.12	$1.27	$1.37	$0.80	$1.86	$1.69	$1.67	$2.41	$1.94	$1.49	$0.88	$4.08
Diluted shares	52.0M	52.2M	52.9M	-	53.8M	54.4M	55.0M	-	55.7M	55.8M	55.8M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Cash and equivalents	$250.00M	$252.00M	$230.00M	$258.00M	$239.00M	$213.00M	$183.00M	$223.00M	$197.00M	$206.00M	$244.00M	$238.00M
Inventory	$566.00M	$522.00M	$503.00M	$504.00M	$531.00M	$541.00M	$536.00M	$552.00M	$553.00M	$551.00M	$617.00M	$585.00M
Current assets	$1.67B	$1.55B	$1.46B	$1.54B	$1.57B	$1.60B	$1.50B	$1.60B	$1.59B	$1.60B	$1.69B	$1.63B
Goodwill	$137.00M	$136.00M	$136.00M	$134.00M	$133.00M	$128.00M	$127.00M	$133.00M	$132.00M	$137.00M	$138.00M	$134.00M
Total assets	$3.98B	$3.90B	$3.76B	$3.81B	$3.84B	$3.78B	$3.64B	$3.74B	$3.58B	$3.60B	$3.69B	$3.60B
Current liabilities	$1.14B	$1.07B	$874.00M	$957.00M	$740.00M	$818.00M	$747.00M	$772.00M	$717.00M	$718.00M	$830.00M	$822.00M
Short-term debt	$261.00M	$261.00M	$260.00M	$260.00M	$10.00M	$9.00M	$9.00M	$8.00M	$8.00M	$8.00M	$8.00M	$8.00M
Long-term debt	$828.00M	$863.00M	$854.00M	$856.00M	$1.10B	$1.09B	$1.09B	$1.09B	$1.08B	$1.09B	$1.10B	$1.09B
Total debt	$1.09B	$1.12B	$1.11B	$1.12B	$1.11B	$1.10B	$1.10B	$1.09B	$1.09B	$1.10B	$1.11B	$1.10B
Total liabilities	$2.24B	$2.21B	$2.03B	$2.11B	$2.15B	$2.19B	$2.13B	$2.15B	$2.08B	$2.09B	$2.22B	$2.20B
Shareholders' equity	$1.60B	$1.69B	$1.73B	$1.55B	$1.68B	$1.59B	$1.51B	$1.59B	$1.50B	$1.51B	$1.48B	$1.41B

Cash flow

Cash flow
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Operating cash flow	$75.00M	$77.00M	$126.00M	$219.00M	$249.00M	$73.00M	$124.00M	$204.00M	$207.00M	$176.00M	$105.00M	$138.00M
Capital expenditures	$38.00M	$45.00M	$69.00M	$64.00M	$61.00M	$72.00M	$77.00M	$92.00M	$52.00M	$43.00M	$54.00M	$78.00M
Free cash flow	$37.00M	$32.00M	$57.00M	$155.00M	$188.00M	$1.00M	$47.00M	$112.00M	$155.00M	$133.00M	$51.00M	$60.00M
Investing cash flow	-$38.00M	-$109.00M	-$69.00M	-$59.00M	-$65.00M	-$70.00M	-$104.00M	-$89.00M	-$51.00M	-$41.00M	-$54.00M	-$75.00M
Financing cash flow	-$49.00M	$53.00M	-$92.00M	-$146.00M	-$183.00M	$17.00M	-$24.00M	-$89.00M	-$131.00M	-$166.00M	-$29.00M	-$32.00M
Dividends paid	$24.00M	$24.00M	$24.00M	$25.00M	$24.00M	$23.00M	$24.00M	$24.00M	$24.00M	$23.00M	$22.00M	$23.00M
Share repurchases	$0	$49.00M	$52.00M	$39.00M	$40.00M	$47.00M	$42.00M	$66.00M	$49.00M	$24.00M	$33.00M	$50.00M
Stock-based compensation	$6.00M	$4.00M	$3.00M	$5.00M	$5.00M	$6.00M	$8.00M	$6.00M	$6.00M	$7.00M	$6.00M	$5.00M
Depreciation and amortization	$50.00M	$49.00M	$41.00M	$40.00M	$39.00M	$38.00M	$37.00M	$37.00M	$36.00M	$37.00M	$41.00M	$37.00M

Key ratios

Key ratios
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Revenue growth, YoY	6.4%	-3.4%	-11.1%	-10.2%	-9.2%	-8.1%	-0.3%	3.7%	5.0%	-1.4%	-0.7%	-13.2%
Net income growth, YoY	-94.1%	-25.7%	-21.2%	-68.6%	-7.3%	8.2%	70.5%	-41.5%	32.9%	18.3%	-7.6%	148.9%
EPS growth, YoY	-93.5%	-24.9%	-18.0%	-66.8%	-4.1%	13.4%	89.8%	-40.9%	35.7%	15.5%	-5.4%	145.8%
Gross margin	18.7%	23.2%	24.9%	24.5%	26.4%	25.7%	24.6%	24.0%	25.2%	24.1%	22.8%	23.3%
Operating margin	10.0%	14.3%	15.2%	15.2%	18.1%	17.3%	16.2%	15.0%	16.9%	15.3%	14.2%	14.7%
Net margin	0.6%	8.6%	9.7%	4.8%	10.9%	11.2%	10.9%	13.7%	10.7%	9.5%	6.4%	24.2%
Free cash flow margin	3.8%	3.5%	6.7%	17.2%	20.4%	0.1%	4.9%	11.2%	15.3%	13.1%	5.3%	6.2%
Current ratio	1.47	1.45	1.67	1.61	2.13	1.96	2.00	2.08	2.22	2.24	2.04	1.98
Debt to equity	0.68	0.67	0.64	0.72	0.66	0.69	0.72	0.69	0.73	0.73	0.75	0.78

Source: XBRL data Cabot Corporation files with the SEC, latest filing dated Aug 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CBT peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CBT	$3.63B	-4.7%	$209.00M	5.8%	$3.73B
LINLinde plc	$36.24B	+8.2%	$7.01B	19.3%	$239.54B
APDAir Products and Chemicals Inc.	$12.60B	+4.5%	-$47.30M	-0.4%	$69.53B
DOWDow Inc.	$42.61B	+4.2%	-$897.00M	-2.1%	$22.78B
IFFInternational Flavors & Fragrances Inc.	$11.69B	+24.3%	$182.00M	1.6%	$20.83B
DDDuPont de Nemours Inc.	$7.06B	+3.2%	$301.00M	4.3%	$20.79B
LYBLyondellBasell Industries NV	$31.96B	+3.5%	$1.30B	4.1%	$19.59B
ALBAlbemarle Corporation	$6.15B	+24.4%	$681.63M	11.1%	$11.20B
SOLSSolstice Advanced Materials Inc.	$4.17B	+9.4%	$325.00M	7.8%	$10.22B

CBT FAQ

9 questions

What is CBT revenue?
Cabot Corporation (CBT) reported $3.63B of revenue for the twelve months ended Jun 30, 2026. That is down 4.7% from the year before. Revenue for fiscal 2025 was $3.71B.
Is CBT profitable?
Yes. Cabot Corporation earned $209.00M in net income for the twelve months ended Jun 30, 2026, a net margin of 5.8%.
How much cash and debt does CBT have?
Cabot Corporation reported $250.00M in cash and cash equivalents and $1.09B of debt on its most recent balance sheet in SEC filings.
How fast is CBT revenue growing?
Cabot Corporation's revenue changed -7.0% in fiscal 2025, to $3.71B. Its compound annual growth rate was +7.3% over 5 years and +2.6% over 10 years.
What is CBT gross margin?
Cabot Corporation's gross profit was $825.00M on $3.63B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 22.7%.
What is CBT free cash flow?
Cabot Corporation generated $281.00M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $497.00M less capital expenditures.
What is CBT earnings per share?
Diluted earnings per share were $3.56 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CBT last report financial results?
The latest statements here come from Cabot Corporation's 10-Q filed on Aug 4, 2026, covering the period ended Jun 30, 2026.
Where does this CBT financial data come from?
Quantisnow builds these statements from the structured XBRL data Cabot Corporation files with the SEC. It is provided for information only and is not investment advice.